“Cardiovascular assessment should begin when the patient is being selected for treatment, not after the toxicity emerges,” said Faisal Mehmud, MD, MRCP.
|Videos|June 10, 2019
Dr. Hala Borno on Addressing Disparities in Access to Prostate Cancer Care
Author(s)Hala Borno, MD
Cancer Network spoke with Hala Borno, MD, of the University of California, San Francisco, about addressing the disparities in access to clinical trials and treatments for patients with prostate cancer.
Advertisement
Cancer Network spoke with Hala Borno, MD, of the University of California, San Francisco, about addressing the disparities in access to clinical trials and treatments for patients with prostate cancer.
Advertisement
Related to this article
Experts preview ASTRO 2026 presentations to watch, including those on SOFT Preop, PSMAgRT, radiosurgery for depression, and AI tools for patient safety.
Advertisement
Advertisement
Trending on CancerNetwork
1
The Case for Frontline Zongertinib in HER2-Mutant NSCLC
2
Isatuximab-Based Therapy Shows “Impressive” PFS Projections in NDMM
3
Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC
4
Emerging Endocrine Doublets and Serial ESR1 Testing in HR+/HER2− mBC
5